Nephron Pharmaceuticals Corp.August 14, 2015

FDA 483 - Nephron Pharmaceuticals Corp. - August 14, 2015

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nephron Pharmaceuticals Corp.

Record Details

This 483 record concerns Nephron Pharmaceuticals Corp., with an inspection on August 14, 2015, issued by the Office of Medical Device and Radiological Health Division II, covering drugs.

Company: Nephron Pharmaceuticals Corp.
Inspection Date: August 14, 2015
Product Type: Drugs
Office: Office of Medical Device and Radiological Health Division II
People: Michael H. Tollon (Approval Manager)
Ileana Barreto-Petit
Ivis L. Negron Torres
Melanie Walker
Jessica L. Pressley (Pharmacy Compounding National Expert, Drug Specialist, Drug Specialist, Foreign Cadre)

Open in Dashboard

ID · 1f3c6d8f-027d-4fb8-a003-5135818d528c